Biotech firms race to recruit good bugs in war on cancer
2017-11-24 20:00
by Kristin Neumann
  Last edited: 2018-02-20 11:48

News from: Ben Hirschler (Reuters)

Biotech firms race to recruit good bugs in war on cancer

A cancer cell being attacked
A cancer cell (white) being attacked by two cytotoxic T cells (red)

(Reuters) - Biotech companies are competing to develop medicines using “bugs as drugs” to fight cancer, building on the latest scientific findings that patients with high levels of good gut bacteria are more likely to respond to modern immunotherapy.

Certain bacteria seem to help in cancer by priming immune cells and smoothing the path for immunotherapy drugs known as PD-1 drugs that work by taking the brakes off the immune system.

Seres Therapeutics hopes to become the first company to leverage this discovery through a collaboration with the MD Anderson Cancer Center in Texas and the Parker Institute for Cancer Immunotherapy that will see its microbe medicine tested in a clinical trial.” Click here to read the full article.

Kristin Neumann, Autor
Kristin Neumann, PhD
Autor

Hello, I am a microbiologist by profession. I studied (molecular) biology because I was always curious about how life functions...

You like what you have read? Share it with your friends.

Go back

Copyright 2019 MyMicrobiome Anstalt - All rights reserved.

DISCLAIMER: Nothing on this site or blog is intended to provide medical advice, diagnosis or treatment.

MyMicrobiome uses cookies to provide the best possible functionality. More info …
Got it!